Difficulty: Medium
Average Score: 68%
Practice
A client has been prescribed denosumab (Prolia). What medication education should the nurse provide?
Correct answer
B
Rationale
The correct answer is B) You may feel more fatigued than usual when taking this drug.
Denosumab (Prolia) is a medication used to treat osteoporosis by inhibiting bone breakdown. Fatigue is a common side effect of denosumab, so it is important for the nurse to educate the client about this potential symptom. This education helps the client anticipate and manage the side effect, leading to better adherence to the medication regimen.
Option A) is incorrect because while denosumab is administered via injection, this information is not the most crucial for the client's understanding and management of their medication.
Option C) is incorrect as it is a general recommendation for any medication regimen and does not specifically relate to the side effects or management of denosumab.
Option D) is incorrect because it is essential for clients taking denosumab to continue with calcium and vitamin D supplements to support bone health. Restricting these supplements can have negative consequences on bone density and overall health.
In an educational context, understanding the side effects and necessary supportive measures for medications is crucial for both nurses and clients. Providing accurate and detailed medication education ensures safe and effective treatment outcomes.
Denosumab (Prolia) is a medication used to treat osteoporosis by inhibiting bone breakdown. Fatigue is a common side effect of denosumab, so it is important for the nurse to educate the client about this potential symptom. This education helps the client anticipate and manage the side effect, leading to better adherence to the medication regimen.
Option A) is incorrect because while denosumab is administered via injection, this information is not the most crucial for the client's understanding and management of their medication.
Option C) is incorrect as it is a general recommendation for any medication regimen and does not specifically relate to the side effects or management of denosumab.
Option D) is incorrect because it is essential for clients taking denosumab to continue with calcium and vitamin D supplements to support bone health. Restricting these supplements can have negative consequences on bone density and overall health.
In an educational context, understanding the side effects and necessary supportive measures for medications is crucial for both nurses and clients. Providing accurate and detailed medication education ensures safe and effective treatment outcomes.